2012

The determinants of tumour immunogenicity.
Blankenstein, T., Coulie, P.G., Gilboa, E. and Jaffee, E.M.
Nature Reviews Cancer 12 (4): 307-313. April 2012

Targeting MET in cancer: rationale and progress.
Gherardi, E., Birchmeier, W. ORCID: https://orcid.org/0000-0003-1173-0829, Birchmeier, C. ORCID: https://orcid.org/0000-0002-2041-8872 and Woude, G.V.
Nature Reviews Cancer 12 (2): 89-103. February 2012

2010

The shunt problem: control of functional shunting in normal and tumour vasculature.
Pries, A.R., Hoepfner, M., le Noble, F. ORCID: https://orcid.org/0000-0001-6195-7672, Dewhirst, M.W. and Secomb, T.W.
Nature Reviews Cancer 10 (8): 587-593. August 2010

2009

The ups and downs of p53: understanding protein dynamics in single cells.
Batchelor, E., Loewer, A. and Lahav, G.
Nature Reviews Cancer 9 (5): 371-377. May 2009

2008

Wnt signalling and its impact on development and cancer.
Klaus, A. ORCID: https://orcid.org/0000-0002-1164-3322 and Birchmeier, W. ORCID: https://orcid.org/0000-0003-1173-0829
Nature Reviews Cancer 8 (5): 387-398. May 2008

2003

Senescence apoptosis and therapy - cutting the lifelines of cancer.
Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226
Nature Reviews Cancer 3 (4): 286-295. April 2003